FDA Clears Mobilett Elara Max from Siemens Healthineers for Enhancements in Mobile X-ray Imaging
Malvern, PA | Mar 20, 2019
• System’s virtual workstation enhances workflow
• Advanced security features ensure patient data safety
The U.S. Food and Drug Administration (FDA) has cleared the Mobilett Elara Max mobile X-ray system from Siemens Healthineers, with features that enable comprehensive IT security as well as secure system integration into the hospital’s IT environment for anytime access to patient data. The system also has an improved design that includes an antimicrobial coating.
The comprehensive security package of the Mobilett Elara Max helps health care facilities handle cyber threats, while its virtual workstation technology provides access to necessary patient information directly at the bedside. The system’s ergonomic design has an antimicrobial coating and fully integrated cables for an unobstructed front view that allows for smooth, safe maneuverability. Additionally, the system delivers 180-degree lateral arm movement that maximizes positioning options to provide customers with robust imaging power for diagnostic confidence.
“Siemens Healthineers is pleased to offer the Mobilett Elara Max, a mobile X-ray system with advanced cybersecurity features that provide state-of-the-art patient data protection,” said Scott Watson, Vice President of X-ray Products, Siemens Healthineers North America. “The system’s virtual workstation digitalizes healthcare by allowing technologists to access important patient information right at the bedside rather than return to the radiology department.”
Contact for journalists
Phone: +484 868-8346; E-mail: email@example.com
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.
In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide. Further information is available at www.siemens-healthineers.com.